Cellectis (CLLS) Cash from Investing Activities (2015 - 2026)
Cellectis (CLLS) posted Cash from Investing Activities of -$6.2 million for Q1 2026, down 127.46% on a QoQ basis from $22.5 million in Q4 2025, and down 245.99% year-over-year from $4.2 million in Q1 2025.
Cellectis (CLLS) has 12 years of Cash from Investing Activities data on file, last reported at -$6.2 million in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 245.99% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$39.9 million (up 58.7% YoY), while the FY2025 annual figure was -$29.5 million, up 71.32% from the prior year.
- Cash from Investing Activities fell to -$6.2 million in Q1 2026, from $22.5 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $22.5 million in Q4 2025 and bottomed at -$106.4 million in Q2 2024.
- A 5-year average of -$9.2 million and a median of -$1.1 million in 2022 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 7544.33% in 2024, down 5916.34% in 2024.
- Year by year, Cash from Investing Activities stood at -$730000.0 in 2022, then slumped by 1759.45% to -$13.6 million in 2023, then dropped by 22.74% to -$16.7 million in 2024, then soared by 234.75% to $22.5 million in 2025, then slumped by 127.46% to -$6.2 million in 2026.
- The last three Cash from Investing Activities figures came in at -$6.2 million (Q1 2026), $22.5 million (Q4 2025), and -$3.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -6.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.17 Mn |
| Mar 31, 2026 | -6.17 Mn |
| Dec 31, 2025 | 22.45 Mn |
| Dec 31, 2025 | 22.45 Mn |
| Sep 30, 2025 | -3.44 Mn |
| Sep 30, 2025 | -3.44 Mn |
| Jun 30, 2025 | -52.72 Mn |
| Jun 30, 2025 | -52.72 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Mar 31, 2025 | 4.22 Mn |
| Dec 31, 2024 | -16.66 Mn |
| Dec 31, 2024 | -16.66 Mn |
| Sep 30, 2024 | 22.33 Mn |
| Sep 30, 2024 | 22.33 Mn |
| Jun 30, 2024 | -106.43 Mn |
| Jun 30, 2024 | -106.43 Mn |
| Mar 31, 2024 | -2.05 Mn |
| Mar 31, 2024 | -2.05 Mn |
| Dec 31, 2023 | -13.57 Mn |
| Dec 31, 2023 | -13.57 Mn |
| Sep 30, 2023 | -300,000.00 |
| Sep 30, 2023 | -300,000.00 |
| Jun 30, 2023 | -1.77 Mn |
| Jun 30, 2023 | -1.77 Mn |
| Mar 31, 2023 | 133,000.00 |
| Mar 31, 2023 | 133,000.00 |
| Dec 31, 2022 | -730,000.00 |
| Dec 31, 2022 | -730,000.00 |
| Sep 30, 2022 | -238,000.00 |
| Sep 30, 2022 | -238,000.00 |
| Jun 30, 2022 | -1.11 Mn |
| Jun 30, 2022 | -1.11 Mn |
| Mar 31, 2022 | -686,000.00 |
| Mar 31, 2022 | -686,000.00 |
| Dec 31, 2021 | -11.18 Mn |
| Dec 31, 2021 | -11.18 Mn |
| Sep 30, 2021 | -2.46 Mn |
| Sep 30, 2021 | -2.46 Mn |
| Jun 30, 2021 | 9.63 Mn |
| Jun 30, 2021 | 9.63 Mn |
| Mar 31, 2021 | 307,000.00 |
| Mar 31, 2021 | 307,000.00 |
| Dec 31, 2020 | 10.06 Mn |
| Dec 31, 2020 | 10.06 Mn |
| Sep 30, 2020 | 2.28 Mn |
| Sep 30, 2020 | 2.28 Mn |
| Jun 30, 2020 | -5.33 Mn |
| Jun 30, 2020 | -5.33 Mn |
| Mar 31, 2020 | -48.55 Mn |
| Mar 31, 2020 | -48.55 Mn |
| Dec 31, 2019 | -2.53 Mn |
| Dec 31, 2019 | -2.53 Mn |
| Sep 30, 2019 | -25.79 Mn |
| Sep 30, 2019 | -25.79 Mn |
| Jun 30, 2019 | -3.09 Mn |
| Jun 30, 2019 | -3.09 Mn |
| Mar 31, 2019 | -4.46 Mn |
| Mar 31, 2019 | -4.46 Mn |
| Dec 31, 2018 | -2.06 Mn |
| Dec 31, 2018 | -2.06 Mn |
| Sep 30, 2018 | 18.38 Mn |
| Sep 30, 2018 | 18.38 Mn |
| Jun 30, 2018 | 19.85 Mn |
| Jun 30, 2018 | 19.85 Mn |
| Mar 31, 2018 | -546,000.00 |
| Mar 31, 2018 | -546,000.00 |
| Dec 31, 2017 | -513,000.00 |
| Dec 31, 2017 | -513,000.00 |
| Sep 30, 2017 | 6.13 Mn |
| Sep 30, 2017 | 6.13 Mn |
| Jun 30, 2017 | -13.11 Mn |
| Jun 30, 2017 | -13.11 Mn |
| Mar 31, 2017 | -2.82 Mn |
| Mar 31, 2017 | -2.82 Mn |
| Dec 31, 2016 | 47.46 Mn |
| Dec 31, 2016 | 47.46 Mn |
| Sep 30, 2016 | 8.33 Mn |
| Sep 30, 2016 | 8.33 Mn |
| Jun 30, 2016 | -5.27 Mn |
| Jun 30, 2016 | -5.27 Mn |
| Mar 31, 2016 | -102.54 Mn |
| Mar 31, 2016 | -102.54 Mn |
| Dec 31, 2015 | -981,024.96 |
| Dec 31, 2015 | -981,024.96 |
| Sep 30, 2015 | -42,266.83 |
| Sep 30, 2015 | -42,266.83 |
| Jun 30, 2015 | -3.42 Mn |
| Jun 30, 2015 | -3.42 Mn |
| Mar 31, 2015 | -3.32 Mn |
| Mar 31, 2015 | -3.32 Mn |